Sumner Andrew Slavin, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammaplasty | 26 | 2013 | 1239 | 2.140 |
Why?
|
| Lymphedema | 16 | 2016 | 525 | 1.830 |
Why?
|
| Breast Implantation | 8 | 2014 | 223 | 1.490 |
Why?
|
| Surgical Flaps | 22 | 2011 | 1671 | 0.980 |
Why?
|
| Tissue Expansion | 6 | 2012 | 160 | 0.860 |
Why?
|
| Breast Implants | 10 | 2012 | 411 | 0.820 |
Why?
|
| Mastectomy | 15 | 2013 | 1822 | 0.670 |
Why?
|
| Breast | 10 | 2012 | 1967 | 0.630 |
Why?
|
| Collagen | 5 | 2013 | 2638 | 0.510 |
Why?
|
| Tissue Expansion Devices | 3 | 2012 | 156 | 0.500 |
Why?
|
| Esthetics | 8 | 2012 | 330 | 0.470 |
Why?
|
| Nipples | 4 | 2009 | 229 | 0.460 |
Why?
|
| Reoperation | 15 | 2013 | 4303 | 0.450 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2014 | 490 | 0.440 |
Why?
|
| Erythema | 1 | 2014 | 262 | 0.430 |
Why?
|
| Lipectomy | 5 | 2012 | 113 | 0.390 |
Why?
|
| Postoperative Complications | 10 | 2018 | 15631 | 0.340 |
Why?
|
| Cancer Care Facilities | 2 | 2009 | 422 | 0.340 |
Why?
|
| Abdominal Wall | 2 | 2007 | 166 | 0.320 |
Why?
|
| Skin Transplantation | 3 | 2012 | 1083 | 0.310 |
Why?
|
| Lymphocele | 1 | 2008 | 18 | 0.310 |
Why?
|
| Subcutaneous Fat | 2 | 2012 | 393 | 0.300 |
Why?
|
| Hospitals, Special | 1 | 2008 | 91 | 0.290 |
Why?
|
| Referral and Consultation | 5 | 2015 | 3600 | 0.280 |
Why?
|
| Rhytidoplasty | 1 | 2008 | 71 | 0.280 |
Why?
|
| Thigh | 1 | 2008 | 241 | 0.280 |
Why?
|
| Breast Neoplasms | 16 | 2012 | 21012 | 0.260 |
Why?
|
| Cicatrix | 3 | 2010 | 798 | 0.260 |
Why?
|
| Blepharoplasty | 1 | 2006 | 61 | 0.250 |
Why?
|
| Phlebotomy | 1 | 2005 | 137 | 0.240 |
Why?
|
| Hematoma | 2 | 2006 | 768 | 0.230 |
Why?
|
| Surgical Mesh | 1 | 2007 | 311 | 0.230 |
Why?
|
| Abdominal Muscles | 4 | 2007 | 169 | 0.220 |
Why?
|
| Prosthesis Design | 1 | 2010 | 2115 | 0.220 |
Why?
|
| Hernia, Ventral | 1 | 2007 | 218 | 0.220 |
Why?
|
| Dexmedetomidine | 1 | 2008 | 319 | 0.220 |
Why?
|
| Program Development | 1 | 2009 | 1297 | 0.220 |
Why?
|
| Biocompatible Materials | 2 | 2011 | 1685 | 0.210 |
Why?
|
| Leg | 2 | 2012 | 1088 | 0.210 |
Why?
|
| Lymphatic System | 3 | 2007 | 254 | 0.200 |
Why?
|
| Blood Pressure Determination | 1 | 2005 | 633 | 0.200 |
Why?
|
| Rhinoplasty | 3 | 2012 | 238 | 0.190 |
Why?
|
| Female | 68 | 2016 | 392644 | 0.180 |
Why?
|
| Edema | 3 | 2012 | 766 | 0.180 |
Why?
|
| Endoscopy | 1 | 2010 | 1851 | 0.170 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 1179 | 0.170 |
Why?
|
| Patient Satisfaction | 7 | 2010 | 3461 | 0.170 |
Why?
|
| Algorithms | 3 | 2008 | 14031 | 0.160 |
Why?
|
| Muscle, Skeletal | 4 | 2007 | 4948 | 0.150 |
Why?
|
| Patient Selection | 1 | 2010 | 4244 | 0.150 |
Why?
|
| Microsurgery | 3 | 2010 | 795 | 0.150 |
Why?
|
| Transplantation Conditioning | 3 | 2002 | 1590 | 0.150 |
Why?
|
| Thoracic Wall | 2 | 2011 | 202 | 0.150 |
Why?
|
| Bariatric Surgery | 1 | 2007 | 992 | 0.140 |
Why?
|
| Surgery, Plastic | 4 | 2018 | 643 | 0.140 |
Why?
|
| Obesity | 3 | 2016 | 12947 | 0.140 |
Why?
|
| Scleroderma, Localized | 1 | 1997 | 87 | 0.130 |
Why?
|
| Adult | 44 | 2015 | 221177 | 0.130 |
Why?
|
| Middle Aged | 40 | 2015 | 220895 | 0.130 |
Why?
|
| Humans | 75 | 2018 | 761504 | 0.130 |
Why?
|
| Mastectomy, Segmental | 3 | 2006 | 955 | 0.130 |
Why?
|
| Lipomatosis | 2 | 1989 | 112 | 0.130 |
Why?
|
| Facial Neoplasms | 2 | 1989 | 125 | 0.130 |
Why?
|
| Contraceptives, Oral | 1 | 2018 | 554 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2015 | 12953 | 0.130 |
Why?
|
| Syndrome | 2 | 2014 | 3267 | 0.120 |
Why?
|
| Models, Animal | 1 | 2001 | 2112 | 0.120 |
Why?
|
| Attitude to Health | 2 | 2014 | 2025 | 0.120 |
Why?
|
| Surgical Sponges | 1 | 2014 | 39 | 0.110 |
Why?
|
| Mastectomy, Modified Radical | 2 | 2009 | 62 | 0.110 |
Why?
|
| Silicones | 1 | 1995 | 228 | 0.110 |
Why?
|
| Cost of Illness | 2 | 2014 | 1936 | 0.110 |
Why?
|
| Lymphography | 2 | 2008 | 188 | 0.110 |
Why?
|
| Medical Tourism | 1 | 2014 | 52 | 0.110 |
Why?
|
| Implant Capsular Contracture | 1 | 2012 | 23 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2004 | 3312 | 0.100 |
Why?
|
| Implants, Experimental | 1 | 2012 | 99 | 0.100 |
Why?
|
| Neoplasms, Second Primary | 1 | 2000 | 1052 | 0.100 |
Why?
|
| Foreign-Body Reaction | 1 | 2012 | 157 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5440 | 0.100 |
Why?
|
| Skin, Artificial | 1 | 2012 | 89 | 0.090 |
Why?
|
| Axilla | 2 | 2011 | 624 | 0.090 |
Why?
|
| Tensile Strength | 2 | 2013 | 330 | 0.090 |
Why?
|
| Lipodystrophy | 1 | 2012 | 145 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 1998 | 1085 | 0.090 |
Why?
|
| Costs and Cost Analysis | 3 | 2012 | 1668 | 0.090 |
Why?
|
| Nasal Obstruction | 1 | 2012 | 160 | 0.090 |
Why?
|
| Radionuclide Imaging | 2 | 2008 | 1972 | 0.090 |
Why?
|
| Foreign Bodies | 1 | 2014 | 402 | 0.080 |
Why?
|
| New England | 2 | 2009 | 1054 | 0.080 |
Why?
|
| Connective Tissue Diseases | 1 | 2012 | 285 | 0.080 |
Why?
|
| Quality of Life | 5 | 2014 | 13367 | 0.080 |
Why?
|
| Materials Testing | 1 | 2012 | 863 | 0.080 |
Why?
|
| Fat Necrosis | 1 | 2008 | 60 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 847 | 0.080 |
Why?
|
| Occlusive Dressings | 1 | 2008 | 52 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2014 | 15842 | 0.070 |
Why?
|
| Lower Extremity | 2 | 2015 | 1202 | 0.070 |
Why?
|
| Regeneration | 1 | 1997 | 1511 | 0.070 |
Why?
|
| Graft Survival | 5 | 2009 | 3819 | 0.070 |
Why?
|
| Groin | 1 | 2008 | 106 | 0.070 |
Why?
|
| Horses | 1 | 2008 | 300 | 0.070 |
Why?
|
| Safety | 2 | 2005 | 1150 | 0.070 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 1380 | 0.070 |
Why?
|
| Fingers | 2 | 1988 | 507 | 0.070 |
Why?
|
| Neck | 1 | 2012 | 734 | 0.070 |
Why?
|
| Nasal Mucosa | 1 | 1990 | 416 | 0.070 |
Why?
|
| Penile Diseases | 1 | 2007 | 45 | 0.070 |
Why?
|
| Treatment Outcome | 10 | 2012 | 64680 | 0.070 |
Why?
|
| Medical Records | 2 | 2009 | 1408 | 0.070 |
Why?
|
| Retrobulbar Hemorrhage | 1 | 2006 | 10 | 0.070 |
Why?
|
| Fascia | 1 | 2007 | 140 | 0.070 |
Why?
|
| Varicose Veins | 1 | 1988 | 155 | 0.070 |
Why?
|
| Male | 24 | 2016 | 360804 | 0.070 |
Why?
|
| Peritoneum | 1 | 2007 | 225 | 0.070 |
Why?
|
| Retrospective Studies | 12 | 2015 | 80636 | 0.060 |
Why?
|
| Malpractice | 1 | 2010 | 556 | 0.060 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2007 | 213 | 0.060 |
Why?
|
| Radiotherapy | 1 | 1992 | 1499 | 0.060 |
Why?
|
| Aged | 17 | 2015 | 169289 | 0.060 |
Why?
|
| Breast Diseases | 2 | 2006 | 442 | 0.060 |
Why?
|
| Cocaine | 1 | 1990 | 958 | 0.060 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 453 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2012 | 39106 | 0.060 |
Why?
|
| Laparotomy | 1 | 2007 | 457 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2000 | 5671 | 0.060 |
Why?
|
| Venous Thromboembolism | 1 | 2018 | 1866 | 0.060 |
Why?
|
| Sodium Chloride | 2 | 1998 | 587 | 0.060 |
Why?
|
| Muscles | 1 | 1989 | 1576 | 0.060 |
Why?
|
| Extremities | 2 | 2007 | 867 | 0.060 |
Why?
|
| Cysts | 1 | 1989 | 681 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2001 | 3615 | 0.060 |
Why?
|
| Peripheral Nerves | 1 | 2007 | 479 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 1998 | 9280 | 0.050 |
Why?
|
| Drainage | 1 | 1989 | 1157 | 0.050 |
Why?
|
| Electric Impedance | 1 | 2007 | 757 | 0.050 |
Why?
|
| Skin | 2 | 1993 | 4484 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 2 | 2009 | 1489 | 0.050 |
Why?
|
| Transplantation, Autologous | 3 | 2007 | 2115 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2007 | 769 | 0.050 |
Why?
|
| Bone Marrow Purging | 2 | 2002 | 108 | 0.050 |
Why?
|
| Vidarabine | 1 | 2002 | 336 | 0.050 |
Why?
|
| Antibodies, Neoplasm | 1 | 2002 | 281 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 1999 | 18252 | 0.050 |
Why?
|
| Adolescent | 10 | 2015 | 88319 | 0.050 |
Why?
|
| Face | 1 | 2007 | 1026 | 0.050 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 1784 | 0.050 |
Why?
|
| Health Care Surveys | 3 | 2014 | 2426 | 0.050 |
Why?
|
| Graft vs Tumor Effect | 1 | 2000 | 68 | 0.040 |
Why?
|
| Actuarial Analysis | 1 | 2000 | 372 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2008 | 1068 | 0.040 |
Why?
|
| Weight Loss | 1 | 2012 | 2684 | 0.040 |
Why?
|
| Wound Healing | 3 | 2007 | 2805 | 0.040 |
Why?
|
| Family | 1 | 2010 | 3194 | 0.040 |
Why?
|
| Fibrosis | 1 | 2006 | 2049 | 0.040 |
Why?
|
| Carcinoma in Situ | 2 | 2008 | 791 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2008 | 1216 | 0.040 |
Why?
|
| Defecation | 1 | 1979 | 190 | 0.040 |
Why?
|
| Logistic Models | 2 | 2009 | 13255 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 1999 | 826 | 0.040 |
Why?
|
| Transplantation Chimera | 1 | 2000 | 594 | 0.040 |
Why?
|
| Internet | 1 | 2010 | 3092 | 0.040 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 12974 | 0.040 |
Why?
|
| Technetium Compounds | 1 | 1997 | 15 | 0.040 |
Why?
|
| Soybean Proteins | 1 | 1997 | 55 | 0.040 |
Why?
|
| Antimony | 1 | 1997 | 20 | 0.040 |
Why?
|
| Hand | 1 | 1983 | 902 | 0.040 |
Why?
|
| Sepsis | 2 | 1983 | 2585 | 0.040 |
Why?
|
| Colloids | 1 | 1997 | 123 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2014 | 1722 | 0.030 |
Why?
|
| Random Allocation | 1 | 2001 | 2395 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 1994 | 6346 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2018 | 250 | 0.030 |
Why?
|
| Thoracic Surgery | 1 | 1983 | 722 | 0.030 |
Why?
|
| Obesity, Morbid | 1 | 2007 | 1277 | 0.030 |
Why?
|
| Methods | 2 | 1988 | 1067 | 0.030 |
Why?
|
| Lectins | 1 | 1997 | 491 | 0.030 |
Why?
|
| Risk Factors | 3 | 2010 | 74206 | 0.030 |
Why?
|
| Young Adult | 5 | 2015 | 59243 | 0.030 |
Why?
|
| Consensus | 1 | 2004 | 3123 | 0.030 |
Why?
|
| Nose | 2 | 2012 | 521 | 0.030 |
Why?
|
| Back | 1 | 1994 | 64 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 1983 | 1161 | 0.030 |
Why?
|
| Mastectomy, Simple | 1 | 1993 | 23 | 0.030 |
Why?
|
| Neoplasm Seeding | 1 | 1994 | 85 | 0.030 |
Why?
|
| Animals | 7 | 2012 | 168459 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 1990 | 4420 | 0.030 |
Why?
|
| Transplantation, Homologous | 3 | 2000 | 4806 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2018 | 617 | 0.030 |
Why?
|
| Mastectomy, Subcutaneous | 1 | 1993 | 56 | 0.030 |
Why?
|
| Lymphoma | 1 | 2002 | 1901 | 0.030 |
Why?
|
| Linear Models | 2 | 2014 | 5871 | 0.030 |
Why?
|
| Bandages | 2 | 2006 | 269 | 0.030 |
Why?
|
| Aging | 1 | 2012 | 8708 | 0.030 |
Why?
|
| Osteomyelitis | 1 | 1997 | 407 | 0.030 |
Why?
|
| Prognosis | 3 | 2015 | 29625 | 0.030 |
Why?
|
| Feces | 1 | 1979 | 1497 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2000 | 6814 | 0.030 |
Why?
|
| Spinal Neoplasms | 1 | 1998 | 716 | 0.020 |
Why?
|
| Graft vs Host Disease | 2 | 2002 | 3029 | 0.020 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2002 | 1640 | 0.020 |
Why?
|
| Staphylococcus | 2 | 1983 | 154 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2015 | 23995 | 0.020 |
Why?
|
| Weight-Bearing | 1 | 2013 | 532 | 0.020 |
Why?
|
| Specialization | 1 | 2015 | 778 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 1998 | 2915 | 0.020 |
Why?
|
| Blindness | 1 | 2014 | 584 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 2006 | 8529 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2015 | 2281 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2018 | 4021 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 1994 | 481 | 0.020 |
Why?
|
| Rectus Abdominis | 1 | 2010 | 103 | 0.020 |
Why?
|
| Cause of Death | 1 | 2000 | 3683 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 26125 | 0.020 |
Why?
|
| Age Distribution | 1 | 2015 | 2880 | 0.020 |
Why?
|
| Survival Rate | 2 | 2000 | 12725 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 1990 | 477 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2000 | 1896 | 0.020 |
Why?
|
| Acute Disease | 1 | 1999 | 7237 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1265 | 0.020 |
Why?
|
| Recurrence | 1 | 2000 | 8465 | 0.020 |
Why?
|
| Carcinoma, Ductal | 1 | 2008 | 97 | 0.020 |
Why?
|
| Hernia | 1 | 1988 | 68 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1994 | 1264 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1989 | 287 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1999 | 3466 | 0.020 |
Why?
|
| Sensation | 1 | 2009 | 337 | 0.020 |
Why?
|
| Health Status | 2 | 2012 | 4077 | 0.020 |
Why?
|
| Scrotum | 1 | 2007 | 116 | 0.020 |
Why?
|
| Carcinoma | 1 | 1998 | 2330 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 1998 | 11121 | 0.020 |
Why?
|
| Biopsy | 1 | 1998 | 6766 | 0.020 |
Why?
|
| Necrosis | 1 | 1990 | 1611 | 0.020 |
Why?
|
| Perineum | 1 | 2007 | 208 | 0.020 |
Why?
|
| Paraplegia | 1 | 2006 | 161 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 9177 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 1993 | 3595 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 3416 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2006 | 188 | 0.020 |
Why?
|
| Time Factors | 4 | 2007 | 39967 | 0.020 |
Why?
|
| Pressure Ulcer | 1 | 2006 | 157 | 0.020 |
Why?
|
| Demography | 1 | 2010 | 1648 | 0.020 |
Why?
|
| Posture | 1 | 1989 | 957 | 0.010 |
Why?
|
| Cellulitis | 1 | 2006 | 209 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2008 | 983 | 0.010 |
Why?
|
| Rats | 2 | 1999 | 23742 | 0.010 |
Why?
|
| Spinal Dysraphism | 1 | 2006 | 178 | 0.010 |
Why?
|
| Thorax | 1 | 2007 | 555 | 0.010 |
Why?
|
| Prospective Studies | 3 | 2012 | 54425 | 0.010 |
Why?
|
| Health Education | 1 | 2010 | 1052 | 0.010 |
Why?
|
| Enterobacter | 1 | 1983 | 44 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2008 | 1813 | 0.010 |
Why?
|
| Biological Dressings | 1 | 1982 | 30 | 0.010 |
Why?
|
| Body Image | 1 | 2008 | 638 | 0.010 |
Why?
|
| Mice | 2 | 2001 | 81525 | 0.010 |
Why?
|
| Thermography | 1 | 1983 | 63 | 0.010 |
Why?
|
| Plethysmography | 1 | 1983 | 175 | 0.010 |
Why?
|
| Child | 4 | 2015 | 80153 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 20570 | 0.010 |
Why?
|
| Streptococcus | 1 | 1983 | 198 | 0.010 |
Why?
|
| Patient Preference | 1 | 2010 | 924 | 0.010 |
Why?
|
| Ultrasonography | 2 | 2008 | 5972 | 0.010 |
Why?
|
| Raynaud Disease | 1 | 1983 | 79 | 0.010 |
Why?
|
| Premedication | 1 | 1983 | 246 | 0.010 |
Why?
|
| United States | 3 | 2018 | 72334 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1989 | 926 | 0.010 |
Why?
|
| Mammography | 1 | 1992 | 2430 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1983 | 441 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1982 | 445 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2015 | 41487 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 2002 | 602 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7390 | 0.010 |
Why?
|
| Transplantation Immunology | 1 | 1982 | 532 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6228 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 2006 | 764 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2002 | 13639 | 0.010 |
Why?
|
| Aneurysm | 1 | 1983 | 337 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 58976 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 5821 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 36426 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 2 | 2002 | 2693 | 0.010 |
Why?
|
| Body Composition | 1 | 2007 | 2426 | 0.010 |
Why?
|
| Electromyography | 1 | 1983 | 1394 | 0.010 |
Why?
|
| Plant Lectins | 1 | 1997 | 103 | 0.010 |
Why?
|
| Angiography | 1 | 1983 | 1595 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 2218 | 0.010 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2006 | 1400 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 3249 | 0.010 |
Why?
|
| Kidney Transplantation | 2 | 1982 | 4234 | 0.010 |
Why?
|
| Decision Making | 1 | 2010 | 3929 | 0.010 |
Why?
|
| Child, Preschool | 3 | 1989 | 42230 | 0.010 |
Why?
|
| Ischemia | 1 | 1983 | 1882 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1982 | 2242 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1989 | 4026 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1999 | 2645 | 0.010 |
Why?
|
| Fees, Medical | 1 | 1993 | 111 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 7967 | 0.010 |
Why?
|
| Remission Induction | 1 | 1997 | 2396 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2006 | 3627 | 0.010 |
Why?
|
| Burns | 1 | 1982 | 1882 | 0.010 |
Why?
|
| Cost Control | 1 | 1993 | 628 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 10090 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13506 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2002 | 11742 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 2088 | 0.000 |
Why?
|
| Thrombosis | 1 | 1983 | 2942 | 0.000 |
Why?
|
| Palliative Care | 1 | 1983 | 3598 | 0.000 |
Why?
|
| Hindlimb | 1 | 1990 | 513 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1997 | 4915 | 0.000 |
Why?
|
| Prostheses and Implants | 1 | 1993 | 1271 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1983 | 7407 | 0.000 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1982 | 228 | 0.000 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1981 | 509 | 0.000 |
Why?
|
| Dogs | 1 | 1981 | 3839 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1990 | 9318 | 0.000 |
Why?
|
| Radiation Dosage | 1 | 1982 | 1958 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1982 | 2911 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1982 | 5486 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1982 | 8002 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1982 | 10194 | 0.000 |
Why?
|